4.7 Article

Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy

Journal

CHEMICAL COMMUNICATIONS
Volume 50, Issue 75, Pages 10945-10948

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c4cc05215c

Keywords

-

Funding

  1. National Natural Science Foundation of China [21172274, 21231007, 21121061, 21201183, J1103305]
  2. State High-Tech Development Program (863 Program) [2012AA020305]
  3. Ministry of Education of China [20100171110013, 313058]
  4. National Basic Research Program of China (973 Program) [2014CB845604]
  5. Fundamental Research Funds for the Central Universities

Ask authors/readers for more resources

The successful design and anticancer mechanistic studies of a series of cyclometalated Ir(III) complexes with histone deacetylase inhibitory and photodynamic therapy (PDT) activities are reported.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available